Literature DB >> 20514556

Vascular effects of antihypertensive drug therapy.

Asia Rehman1, Ernesto L Schiffrin.   

Abstract

Hypertension is associated with structural and functional alterations in the vasculature that lead to hemodynamic disturbances and target organ damage. The benefit of reducing blood pressure on risk reduction is well established. Antihypertensive drugs partially correct hypertensive vascular changes by a number of mechanisms, but their influence may vary in different vascular beds. Recently, combinations of drugs with complementary or synergistic effects have shown favorable effects on the vasculature; these combinations may contribute to risk reduction and improve outcomes in the future. Clinical trial evidence has shown an improvement in morbidity and mortality indicators that could be related to vascular effects of antihypertensive drugs, but this effect needs to be proven in future long-term prospective studies involving simultaneous evaluation of small-artery and large-artery properties.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20514556     DOI: 10.1007/s11906-010-0117-3

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  68 in total

1.  Predicting hypertension complications from small artery structure.

Authors:  Anthony M Heagerty
Journal:  J Hypertens       Date:  2007-05       Impact factor: 4.844

2.  Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients.

Authors:  A Ichihara; Y Kaneshiro; T Takemitsu; M Sakoda
Journal:  J Hum Hypertens       Date:  2006-06-29       Impact factor: 3.012

3.  Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker.

Authors:  E L Schiffrin; L Y Deng; P Larochelle
Journal:  Am J Hypertens       Date:  1995-03       Impact factor: 2.689

4.  Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients.

Authors:  Ernesto L Schiffrin; Qian Pu; Jeong Bae Park
Journal:  Am J Hypertens       Date:  2002-02       Impact factor: 2.689

5.  Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease.

Authors:  B Schwartzkopff; M Brehm; M Mundhenke; B E Strauer
Journal:  Hypertension       Date:  2000-08       Impact factor: 10.190

Review 6.  Effects of antihypertensive treatment on small artery remodelling.

Authors:  Enrico Agabiti-Rosei; Anthony M Heagerty; Damiano Rizzoni
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

7.  Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan.

Authors:  Taishi Nakamura; Eiichiro Yamamoto; Keiichiro Kataoka; Takuro Yamashita; Yoshiko Tokutomi; Yi-Fei Dong; Shinji Matsuba; Hisao Ogawa; Shokei Kim-Mitsuyama
Journal:  Hypertension       Date:  2007-12-24       Impact factor: 10.190

8.  Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients.

Authors:  D Versari; A Virdis; L Ghiadoni; E Daghini; E Duranti; S Masi; A Magagna; S Taddei
Journal:  Atherosclerosis       Date:  2008-12-03       Impact factor: 5.162

9.  A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension.

Authors:  Markus Kosch; Andrea Levers; Detlef Lang; Valerie Bartels; Karl Heinz Rahn; Hermann Pavenstädt; Martin Hausberg
Journal:  Nephrol Dial Transplant       Date:  2008-01-14       Impact factor: 5.992

10.  Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients.

Authors:  Arrigo F G Cicero; Maddalena Veronesi; Maria Grazia Prandin; Valentina Di Gregori; Ettore Ambrosioni; Claudio Borghi
Journal:  Fundam Clin Pharmacol       Date:  2009-06-25       Impact factor: 2.748

View more
  11 in total

Review 1.  Interactions between macro- and micro-circulation: are they relevant?

Authors:  Damiano Rizzoni; Carolina De Ciuceis; Massimo Salvetti; Anna Paini; Claudia Rossini; Claudia Agabiti-Rosei; Maria Lorenza Muiesan
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-14

2.  TLR4 as a possible key regulator of pathological vascular remodeling by Ang II receptor activation.

Authors:  Kouichi Tamura; Tomohiko Kanaoka; Ryu Kobayashi; Kohji Ohki; Masato Ohsawa
Journal:  Hypertens Res       Date:  2015-05-21       Impact factor: 3.872

Review 3.  Vascular Aging and Disease of the Small Vessels.

Authors:  Damiano Rizzoni; Marco Rizzoni; Matteo Nardin; Giulia Chiarini; Claudia Agabiti-Rosei; Carlo Aggiusti; Anna Paini; Massimo Salvetti; Maria Lorenza Muiesan
Journal:  High Blood Press Cardiovasc Prev       Date:  2019-05-29

Review 4.  Treatment of arterial remodeling in essential hypertension.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

5.  Appropriateness of cardiovascular care in elderly adult cancer survivors.

Authors:  Winson Y Cheung; Raisa Levin; Soko Setoguchi
Journal:  Med Oncol       Date:  2013-04-06       Impact factor: 3.064

6.  Plasticity of TRPV1-Expressing Sensory Neurons Mediating Autonomic Dysreflexia Following Spinal Cord Injury.

Authors:  Leanne M Ramer; A Peter van Stolk; Jessica A Inskip; Matt S Ramer; Andrei V Krassioukov
Journal:  Front Physiol       Date:  2012-07-09       Impact factor: 4.566

7.  Differential regulation of nitric oxide synthase function in aorta and tail artery from 5/6 nephrectomized rats.

Authors:  Frank T Spradley; John J White; William D Paulson; David M Pollock; Jennifer S Pollock
Journal:  Physiol Rep       Date:  2013-11-05

8.  Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.

Authors:  Laura Cella; Vittoria D'Avino; Raffaele Liuzzi; Manuel Conson; Francesca Doria; Adriana Faiella; Filomena Loffredo; Marco Salvatore; Roberto Pacelli
Journal:  Radiat Oncol       Date:  2013-09-23       Impact factor: 3.481

9.  Individualization of antihypertensive drug treatment.

Authors:  Giuseppe Mancia; Guido Grassi
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

10.  Short-term esmolol improves coronary artery remodeling in spontaneously hypertensive rats through increased nitric oxide bioavailability and superoxide dismutase activity.

Authors:  Ana Arnalich-Montiel; María Carmen González; Emilio Delgado-Baeza; María Jesús Delgado-Martos; Luis Condezo-Hoyos; Antonia Martos-Rodríguez; Pilar Rodríguez-Rodríguez; Begoña Quintana-Villamandos
Journal:  Biomed Res Int       Date:  2014-03-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.